EP1244664A1 - Composes et methodes de traitement de la douleur - Google Patents

Composes et methodes de traitement de la douleur

Info

Publication number
EP1244664A1
EP1244664A1 EP00989117A EP00989117A EP1244664A1 EP 1244664 A1 EP1244664 A1 EP 1244664A1 EP 00989117 A EP00989117 A EP 00989117A EP 00989117 A EP00989117 A EP 00989117A EP 1244664 A1 EP1244664 A1 EP 1244664A1
Authority
EP
European Patent Office
Prior art keywords
halo
chloro
dione
substituents
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00989117A
Other languages
German (de)
English (en)
Inventor
Megan AstraZeneca MURPHY
Rebecca Ann AstraZeneca URBANEK
Wenhua AstraZeneca XIAO
Gary Banks AstraZeneca STEELMAN
Dean Gordon AstraZeneca BROWN
Thomas Michael Bare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of EP1244664A1 publication Critical patent/EP1244664A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne des composés de la formule (I) dans laquelle R1, A et D sont tels que définis dans le mémorandum descriptif. Elle concerne également des méthodes de traitement de la douleur, qui consistent à administer une quantité effective d'un composé de la formule (I) pouvant atténuer la douleur, et des compositions pharmaceutiques contenant une quantité effective d'un composé de la formule (I) pouvant atténuer la douleur.
EP00989117A 1999-12-23 2000-12-19 Composes et methodes de traitement de la douleur Withdrawn EP1244664A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US171906P 1999-12-23
US23678600P 2000-09-29 2000-09-29
US236786P 2000-09-29
PCT/SE2000/002609 WO2001047925A1 (fr) 1999-12-23 2000-12-19 Composes et methodes de traitement de la douleur

Publications (1)

Publication Number Publication Date
EP1244664A1 true EP1244664A1 (fr) 2002-10-02

Family

ID=26867558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00989117A Withdrawn EP1244664A1 (fr) 1999-12-23 2000-12-19 Composes et methodes de traitement de la douleur

Country Status (4)

Country Link
EP (1) EP1244664A1 (fr)
JP (1) JP2003519147A (fr)
AU (1) AU2566201A (fr)
WO (1) WO2001047925A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7295631B2 (en) 2001-05-14 2007-11-13 Sony Deutschland Gmbh Stereo demultiplexer

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150202A0 (en) * 1999-12-23 2002-12-01 Astrazeneca Ab Method and composition for the treatment of pain
WO2002026739A1 (fr) * 2000-09-29 2002-04-04 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones et leur utilisation pour le traitement de la douleur
WO2002026738A1 (fr) * 2000-09-29 2002-04-04 Astrazeneca Ab 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES ET LEUR UTILISATION POUR TRAITER LA DOULEUR
US6946463B2 (en) 2000-09-29 2005-09-20 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
JP7153471B2 (ja) 2018-05-31 2022-10-14 スリーエム イノベイティブ プロパティズ カンパニー フィルター及び金属イオン除去装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
GB9507318D0 (en) * 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0147925A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7295631B2 (en) 2001-05-14 2007-11-13 Sony Deutschland Gmbh Stereo demultiplexer

Also Published As

Publication number Publication date
WO2001047925A1 (fr) 2001-07-05
JP2003519147A (ja) 2003-06-17
AU2566201A (en) 2001-07-09

Similar Documents

Publication Publication Date Title
US20030181449A1 (en) Methods and compositions for the treatment of pain
EP1244663B1 (fr) Composes et procedes pour le traitement de la douleur
EP1244664A1 (fr) Composes et methodes de traitement de la douleur
AU783499B2 (en) Method and composition for the treatment of pain
EP1244453A1 (fr) Methode et composition pour traiter la douleur
US6730675B2 (en) Compounds and methods for the treatment of pain
EP1244662B1 (fr) Compose pyridazino quinoline et procede de traitement de la douleur
US20050124622A1 (en) Compounds and methods for the treatment of pain
US20030153571A1 (en) Method and composition for the treatment of pain
US6833368B2 (en) 1, 2, 5, 10-tetrahydropyridazino[4, 5-b]quinoline-1,10-diones and their use for the treatment of pain
EP1325004A1 (fr) 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones et leur utilisation pour le traitement de la douleur
US20030176435A1 (en) Compounds and methods for the treatment of pain
US20050070544A1 (en) 1,2,5,10-tetrahydropyridazino{4,5-b}quinoline-1,10-diones and their use for the treatment of pain
US20050101603A1 (en) Compound and method for the treatment of pain
AU2005201344A1 (en) Compound and method for the treatment of pain
EP1577311A1 (fr) Sels de composé pyridazino quinoline et utilisation dans le traitement de la douleur

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020723

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20030509

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050314